Literature DB >> 35583737

Recombineering in Staphylococcus aureus.

Kelsi Penewit1, Stephen J Salipante2.   

Abstract

Recombineering has proven to be an extraordinarily powerful and versatile approach for the modification of bacterial genomes, but has historically not been possible in the important opportunistic pathogen Staphylococcus aureus. After evaluating the activity of various recombinases in S. aureus, we developed methods for recombineering in that organism using synthetic, single-stranded DNA oligonucleotides. This approach can be coupled to CRISPR/Cas9-mediated lethal counterselection in order to improve the efficiency with which recombinant S. aureus are recovered, which is especially useful in instances where mutants lack a selectable phenotype. These methods provide a rapid, scalable, precise, and inexpensive means to engineer point mutations, variable-length deletions, and short insertions into the S. aureus genome.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Genetic engineering; Genome editing; Isogenic strain; Mutagenesis; Recombineering; Staphylococcus aureus

Mesh:

Substances:

Year:  2022        PMID: 35583737     DOI: 10.1007/978-1-0716-2233-9_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides.

Authors:  H M Ellis; D Yu; T DiTizio; D L Court
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 2.  Exploiting CRISPR-Cas immune systems for genome editing in bacteria.

Authors:  Rodolphe Barrangou; Jan-Peter van Pijkeren
Journal:  Curr Opin Biotechnol       Date:  2015-11-26       Impact factor: 9.740

Review 3.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

4.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.

Authors:  Heiman F L Wertheim; Margreet C Vos; Alewijn Ott; Alex van Belkum; Andreas Voss; Jan A J W Kluytmans; Peter H J van Keulen; Christina M J E Vandenbroucke-Grauls; Marlene H M Meester; Henri A Verbrugh
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

6.  Recombineering: a homologous recombination-based method of genetic engineering.

Authors:  Shyam K Sharan; Lynn C Thomason; Sergey G Kuznetsov; Donald L Court
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  Identification and analysis of recombineering functions from Gram-negative and Gram-positive bacteria and their phages.

Authors:  Simanti Datta; Nina Costantino; Xiaomei Zhou; Donald L Court
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

9.  The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli.

Authors:  Chris R Reisch; Kristala L J Prather
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

Review 10.  An update on the molecular genetics toolbox for staphylococci.

Authors:  Marcel Prax; Chia Y Lee; Ralph Bertram
Journal:  Microbiology       Date:  2013-02-01       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.